Schimpff Sc
14 papers receiving 613 citations
Peers
Comparison fields: 5 of 56
- Oncology 467
- Applied Microbiology and Biotechnology 20
- Molecular Medicine 46
- Pharmacology 102
- Infectious Diseases 87
Countries citing papers authored by Schimpff Sc
This map shows the geographic impact of Schimpff Sc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schimpff Sc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schimpff Sc more than expected).
Fields of papers citing papers by Schimpff Sc
This network shows the impact of papers produced by Schimpff Sc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schimpff Sc. The network helps show where Schimpff Sc may publish in the future.
Co-authors
The 14 scholars most cited alongside Schimpff Sc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. | 1978 | 384 |
| 2 | Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. | 1974 | 250 |
| 3 | A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. | 1986 | 48 |
| 4 | Empiric antibiotic therapy. | 1978 | 46 |
| 5 | Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient. | 1983 | 35 |
| 6 | Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia. | 1985 | 21 |
| 7 | Empiric antibiotic therapy for granulocytopenic patients. | 1982 | 14 |
| 8 | Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin. | 1977 | 10 |
| 9 | A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients. | 1979 | 10 |
| 10 | Evaluation of radiotherapay for localized inflammatory skin and perianal lesions in adult leukemia: A porspectively randomized double blind study. | 1977 | 8 |
| 11 | In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients. | 1979 | 3 |
| 12 | Dual lumen catheters for angioaccess in patients with leukemia. | 1983 | 3 |
| 13 | Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization. | 1983 | 3 |
| 14 | Schimpff tells prevention strategies. | 1978 | 1 |
About Schimpff Sc
Schimpff Sc is a scholar working on Oncology, Emergency Medical Services, Infectious Diseases, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 14 papers that have together received 836 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (8 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Occupational Health and Safety in Workplaces (1 paper), Health Promotion and Cardiovascular Prevention (1 paper), Antibiotic Resistance in Bacteria (1 paper), Public Health Policies and Education (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Oncology (467 citations), Applied Microbiology and Biotechnology (20 citations), Molecular Medicine (46 citations), Pharmacology (102 citations) and Infectious Diseases (87 citations). Frequent co-authors include Jean A. Klastersky, M.H.N. Tattersall, Zinner Sh, H. Gaya, A S Levine, Young Rc, Robert G. Graw, Joseph Aisner, Philip A. Pizzo and Peter H. Wiernik. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.